Treatment of heparin-induced thrombocytopenia after cardiac surgery: Preliminary experience with fondaparinux

Journal of Thoracic and Cardiovascular Surgery

Volumn 139, Issue 3, 2010, Pages 790-792

  Pappalardo, Federico ^a   Scandroglio, Annamara ^a   Maj, Giulia ^a   Zangrillo, Alberto ^a   D'Angelo, Armando ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTIBODY TITER; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; CRITICAL ILLNESS; DRUG WITHDRAWAL; HEART SURGERY; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT;

ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; COHORT STUDIES; HEPARIN; HUMANS; POLYSACCHARIDES; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 76749084362     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.11.032     Document Type: Article

References (5)

1. Papadopoulos S., Flynn J.D., and Lewis D.A. Fondaparinux as a treatment option for heparin-induced thrombocytopenia. Pharmacotherapy 27 (2007) 921-926
2. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment and prevention: the Seventh ACCP Conference on Antithrombotic and thrombolytic therapy. Chest 127 (2005) 416
3. Ansell J. Factor Xa or thrombin: is factor Xa a better target?. J Thromb Haemost 5 Suppl 1 (2007) 60-64
4. Grand'Maison A., Charest A.F., and Geerts W.H. Anticoagulant use in patients with chronic renal failure. Am J Cardiovasc Drugs 5 (2005) 291-305
5. Fox K.A., Bassand J.P., Mehta S.R., et al. Oasis 5 Investigators. Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST segment elevation acute coronary syndromes. Ann Intern Med 147 (2007) 304-310